Culture

Autism theory 25 years in the making

image: T.A. Meridian McDonald, PhD, a research instructor in Neurology at Vanderbilt University Medical Center

Image: 
Vanderbilt University Medical Center

A unifying explanation of the cause of autism and the reason for its rising prevalence has eluded scientists for decades, but a theoretical model published in the journal Medical Hypotheses describes the cause as a combination of socially valued traits, common in autism, and any number of co-occurring disabilities.

T.A. Meridian McDonald, PhD, a research instructor in Neurology at Vanderbilt University Medical Center, has spent 25 years researching autism, from a time she could read literally every research paper on the topic in the 1990s until now, when there is an overload of such studies.

"Up until now there have been a lot of theories about the possible causes of autism but none of those theories account for the majority of autism cases," McDonald said. "There are also a lot of theories as to why the prevalence of autism has been increasing in the population but, to date, there hasn't been a theory that provides an explanatory model that accounts for all of those phenomena, including the genetics, social history, or characteristics of autism."

The CDC estimates that 1-in-54 persons are on the autism spectrum.

Consistent with Genetics Research in Autism

McDonald's theory, titled 'The Broader Autism Phenotype Constellation-Disability Matrix Paradigm (BAPCO-DMAP) Theory,' is consistent with the current science on the genetics of autism but shifts the focus to positive traits of autism and to historical events that changed the prevalence of autism in society.

"The BAPCO-DMAP theory describes how people are attracted to other people who are very similar. They are attracted to certain traits that are very common in the population, and this leads to offspring who are more likely to have certain traits, as well as a greater intensity of traits." McDonald said.

"The (BAPCO) traits are not what people expect. They expect the traits to be about challenges or difficulties, but instead there are six main traits -- increased attention, increased memory, a preference for the object world vs. the social world and their environment, increased nonconformity, increased differences in sensory and perception, as well as systemizing."

BAPCO Can Interact with Development

BAPCO traits alone are not necessarily disabling. A person can have BAPCO traits and still have excellent communication and socialization skills, but too much of any of these traits can affect development.

For example, although it seems counterintuitive, McDonald outlines how increased memory and attention can delay language development in children with BAPCO traits.

"Typical babies have tiny attention spans and working memory. These limitations on memory and attention actually help babies learn their first language by breaking the words into their tiniest parts," she said.

"But an infant with very high levels of attention and memory has a harder time with learning language because they are unable to break the language down to very small parts, so they learn groups of sounds instead."

McDonald describes how increased memory and attention can lead to echolalia, where children speak in, or repeat, long phrases without seeming to understand them.

"You can often see children with autism engaging in sense-making activities, such as watching the same show over and over and memorizing information," she said.

BAPCO Can Interact with Disabilities

BAPCO traits can also interact with disabilities. If a person has BAPCO traits and they also have a disability such as Down syndrome or information processing disorder, then those things combined can create greater challenges than what would be experienced by an individual who has only a BAPCO personality or a disability, but not both.

Increased Prevalence of BAPCO and Autism

McDonald's theory also highlights how the prevalence of autism has increased in higher income countries due to societal changes that increase freedoms in education, employment and other opportunities for both men and women.

In societies where people do not have freedom to pursue their interests and passions, where meritorious education is not valued, where men and women do not have freedom to choose their careers, and where nonconformity is not tolerated, McDonald predicts the frequency of BAPCO traits in these populations will be very low.

"The frequency and intensity of BAPCO traits in the U.S. have increased, for example, because individuals are more likely to meet and have children with other individuals with similar education, occupations and interests than would have been possible 100 years ago," she said.

"When men and women with BAPCO traits have children it can increase both the frequency and intensity of BAPCO traits in the population."

No Cure for Autism

McDonald said she now knows what causes autism but it is not something that could be cured and, honestly, she wouldn't want to do that.

"What we call 'autism' is the BAPCO personality combined with a disability or very intense BAPCO traits," she said. "Because the BAPCO is made of socially valued traits, it is not possible to cure autism. Instead, we need to focus on the full range of disabilities that affect people with and without the BAPCO personality."

McDonald said future research should focus on the causes and treatment of underlying disabilities and also on providing supports such as interventions for individuals with disabilities, including those who have this combination of BAPCO and disability intersection.

"When we talk about autism we need to address the developmental disabilities that these individuals are experiencing but also find way to support and enhance their broader autism trait constellations," she said.

Credit: 
Vanderbilt University Medical Center

Scientists from St. Petersburg University discovered the virus-like particles in Bryozoa

image: Bugula neritina. Colony collected intertidally on Atlantic Beach, USA.

Image: 
SPbU

Scientists from Russia, Austria, and the USA have discovered virus-like particles in the bacterial symbionts of Bryozoa - a phylum of colonial aquatic invertebrates - filter-feeders dominating in many bottom ecosystems. The research project was planned and supervised by scientists from St Petersburg University. Some of the virus-like particles resemble red blood cells, while others have a sea-urchin-like appearance. Although viruses have never been reported inside symbiotic bacteria in bryozoans, scientists suggest that this "matryoshka doll" may have a prominent effect on the bacterial hosts.

Life of most organisms on our planet is closely associated with bacterial communities - microbiota that plays a very important role in the health of the host from helping to control digestion to protection of the host from infections. Bryozoa are not an exception. Inside some of these invertebrates the symbiotic bacteria live that, e.g. make larvae not eatable for fish. Yet how the symbiosis can benefit the host itself still remains a mystery. Scientists from the St Petersburg University tried to solve it and eventually made an unexpected discovery.

They encountered the virus-like particles in the colonies of the cheilostome bryozoan Bugula neritina that were intertidally collected from the east coastal area of the USA, and in Paralicornia sinuosa that was collected near Australia. Between bacteria of B. neritina the virus-like particles were found that resembled red blood cells. The particles found inside and between bacteria of P. sinuosa were reminiscent the sea urchins. These were spherical and consisting of cylindrical/tube-like elements evenly radiating from the central double-walled 'core'. To gain a better understanding of what the particles are and what role they play in the life of moss animals the biologists from the University established a collaboration with experts from the Winogradsky Institute of Microbiology, the Russian Academy of Sciences.

'So-called "urchins" from the Australian bryozoan is much alike the "metamorphosis associated contractile structures (MACs)" described by the American scientists in 2014. These structures can be found inside the biofilm-forming marine bacteria Pseudoalteromonas luteoviolacea. MACs have the same origin as the viruses-bacteriophages. In fact, ???s are an assemblage of multiple contractile systems related to the contractile tails of myoviruses (tailed bacteriophages with contractile tails). Contacting the biofilms of Pseudoalteromonas can induce larval metamorphosis in the tubeworm Hydroides elegans. When settling, the larvae of H. elegans contact the biofilm at sea bottom, and the "urchins"' inside the biofilm inject a protein signal into the cells of the larvae. The delivery of the protein induces larval metamorphosis,' said Professor Andrey Letarov, Head of the Laboratory of Microbial Viruses at the Winogradsky Institute of Microbiology, RAS.

Yet there are some differences, Dr Letarov explained. The 'urchins' inside the bacteria that were studied by the Americans are very large and not 'well-organized', while the particles inside the bacteria of Paralicornia sinuosa are finely structured into tiny spheres. But generally speaking, there is much in common between these structures. What role the 'urchins' play in this biological system remains unclear. Yet there is some tentative evidence.

'We know that in some bryozoan species, in particular in Bugula neritina, bacteria from maternal tissues are transmitted to larvae thus providing the vertical transfer of the symbionts between bryozoan generations. Viruses should be transmitted together with bacteria. Yet not all of the bacteria are moved into the larvae. Those that remain in the host can multiply producing an excess of toxic metabolites. This can pose a potential threat to the host. Presumably, the newly discovered viruses can destroy these bacteria thus regulating the symbiont number in the bryozoan hosts,' said Andrew Ostrovsky, Professor at the Department of Invertebrate Zoology, St Petersburg University, and head of the research project.

'The Mac-like structures ("urchins") found in the Australian bryozoan also destroy bacteria. Yet it remains unclear whether they have analogous functions as in the system P. luteoviolaceae - H. elegans. In other words, whether they can deliver a signal from bacterial symbionts to the host,' added Dr Letarov.

Much has to be done, especially in respect to molecular processes in which the virus-like particles can be involved. The scientists are planning to sequence the genome of bacteria containing these virus-like particles to reveal genetic information that regulates their formation. The work will be done in collaboration with bioinformaticians. This may help in gaining a better understanding of what proteins are produced by the 'urchins' and how they can influence other parts of this biological "matryoshka".

Yet collecting fresh bryozoan colonies to continue this research is rather difficult task. Cultivation of the bryozoan symbiotic bacteria in the laboratory was never successful. They can be collected only in their natural habitats, which are the coastal area of Australia and east coastal area of the USA. But even getting there, especially during the current pandemic, is very difficult. This makes scientists think about finding the similar symbiotic systems near the Marine Biological Station of the University at the White Sea. Among bryozoans found in the region, some species possess bacteria.

'Viruses are non-cellular infectious agents. Presumably, they are the most numerous 'particles of life' on the planet. They can replicate, i.e. make copies of themselves, by using bacteria, archaea, protists, fungi, plants, and animals. In other words, all living organisms,' Andrew Ostrovsky said. 'It is a gigantic world that dates back to the period when cellular life on Earth began. Not surprisingly then that viruses are deeply involved in regulation of many processes in living organisms. Without viruses, life and the planet would not exist.'

Credit: 
St. Petersburg State University

Novel RNA factors may help cancer cells thrive

Like Peter Pan, some cells never grow up. In cancer, undifferentiated stem cells may help tumors such as glioblastoma become more aggressive than other forms of the disease. Certain groups of genes are supposed to help cells along the path to maturity, leaving their youthful "stemness" behind. This requires sweeping changes in the microRNAome -- the world of small non-coding material, known as microRNAs, that control where and when genes are turned on and off. Many microRNAs are tumor-suppressive; in cancer, the microRNAome is distorted and disrupted. Recent work by researchers at Brigham and Women's Hospital pinpoints critical changes in an enzyme known as DICER, which create a cascade of effects on this microRNAome. The team identified primary actors circ2082, a circular RNA, and RBM3, an RNA-binding protein, which form a complex with DICER to trap it in the nucleus of glioblastoma cells, therefore disrupting the cytoplasmic microRNAome. Findings are published in Science Advances.

"We are always trying to find the magic bullet to fight cancer. The problem with the magic bullet is that it's only going to hit a few tumor cells, since the other tumor cells don't have that target. We are looking for the common vulnerability -- what is the common thing that we can target?" said Antonio Chiocca, MD, PhD, chair of the Brigham's Department of Neurosurgery. "With this discovery, we can target something way upstream: a very common target at the epigenetic level."

Prior research showed the number of microRNAs expressed in cancer cells to be low when compared to non-cancerous cells. In addressing this observation, primary researchers Jakub Godlewski, PhD, and Agnieszka Bronisz, PhD, both formerly at the Brigham and now based at the Mossakowski Medical Research Centre of Polish Academy of Sciences, Warsaw, Poland, led a team that determined the absence of DICER enzyme is likely the cause of this cytoplasmic microRNA depletion. The team discovered DICER was being trapped in the nucleus by repressive interactions with RBM3 and circ2082.

In order to characterize these new actors, researchers used patient-derived glioblastoma cells, which allowed them to study outcomes genetically and phenotypically similar to real patient outcomes. The cells were studied both in vitro and in vivo through implantation into the brains of lab mice. The level of microRNA expression in these mice changed their survival rates. If circ2082 was knocked down, the nuclear DICER complex of circ2082, DICER, and RBM3 was disrupted, more microRNAs were present in the cytoplasm, and the survival outcome was far greater. In these mice whose tumors had circ2082 knocked down, death by tumorigenesis never occurred, while their non-knockdown counterparts all experienced death by tumorigenesis.

The downstream effect of this circ2082 expression also heavily influenced morbidity in human patients whose tissues were retrospectively analyzed. Patients with circ2082-dependent signature less widely expressed had overall longer lifespans after cancer diagnosis.

"Targeting these upstream tumor proliferators has the potential to dramatically change the cancer treatment landscape," said Chiocca. "We look forward to clinical translation of this research as we search for the right inhibitors."

Credit: 
Brigham and Women's Hospital

Botulism breakthrough? Taming botulinum toxin to deliver therapeutics

image: The toxin-based delivery platform consists of the modified botulinum toxin at upper left (protease domain in gold, translocation domain in blue, and receptor-binding domain in purple) and the nanobody (the pink tag). When this nanobody-toxin fusion protein binds to the receptor (cyan) on the neuron surface, the cell takes it in through the process of endocytosis, corralling the fusion protein inside a vesicle (light green circle). The toxin's protease domain, carrying the nanobody, then crosses into the interior of the cell.

Image: 
Sicai Zhang/Dong Lab, Boston Children's Hospital

While rare, botulism can cause paralysis and is potentially fatal. It is caused by nerve-damaging toxins produced by Clostridium botulinum -- the most potent toxins known. These toxins are often found in contaminated food (home canning being a major culprit). Infants can also develop botulism from ingesting C. botulinum spores in honey, soil, or dust; the bacterium then colonizes their intestines and produces the toxin.

Once paralysis develops, there is no way to reverse it, other than waiting for the toxins to wear off. People with serious cases of botulism may need to be maintained on ventilators for weeks or months. But a new treatment approach and delivery vehicle, described today (?) in Science Translational Medicine, could change that.

"There are anti-toxins, but these only work before the toxins enter the motor neurons," says Min Dong, PhD, a researcher in Boston Children's Hospital's Department of Urology and corresponding author on the paper. "What we have developed is the first therapy that can eliminate toxins after they get inside neurons."

If proven in humans, the approach would represent a breakthrough in treating botulism. In mice, the treatment successfully got inside neurons, reversed muscle paralysis within hours, and enabled mice to withstand doses of botulinum toxin that would otherwise be lethal.

Letting a toxin lead the way

Dong and his colleagues needed to surmount two technical barriers that have prevented the botulism from being treated effectively in the past. Intriguingly, their solution lay in botulinum toxin itself.

"One barrier to treatment has been getting across the cell membrane, which is difficult for protein drugs," explains Shin-Ichiro Miyashita, PhD, a postdoctoral fellow in Dong's lab and first author on the paper. "The other is targeting specific cell types, and in this case specificity toward motor neurons and nerve terminals. We took advantage of the fact that botulinum neurotoxins target motor neurons naturally and efficiently, and can deliver a protein cargo across cell membranes."

The treatment is therefore two-pronged. A botulinum toxin (detoxified through introduced mutations) is the delivery vehicle. The cargo -- i.e., the active drug -- is a mini-antibody derived from the antibodies of camels, developed by collaborator Charles Shoemaker, PhD, at Tufts University. The team showed that two of these so-called nanobodies can be delivered in tandem into neurons, neutralizing botulinum toxins type A and B at one go.

But there was one more problem to solve.

"This idea and approach had been attempted, but it was difficult to completely get rid of toxicity," says Dong, "until we identified a new toxin, botulinum neurotoxin X, in 2017. Unlike other botulinum toxins, this new toxin shows no toxicity after we introduce mutations, and serves as a safe delivery tool."

Botox reversal

Besides botulism, Dong thinks the new treatment could be useful as a "botox reversal" agent. Botox injections, using tiny quantities of the type A botulinum toxin, can safely treat wrinkles and many other medical conditions like neck spasms, excessive sweating, or overactive bladder. However, when the injection goes awry, botox can cause unwanted muscle paralysis as a side effect, and patients have to live with the paralysis for months.

"We can potentially inject our therapeutic protein and get rid of botox in neurons and paralysis within a few hours," Dong says.

A general delivery platform for neuroactive drugs?

The toxin-guided approach may offer a platform for getting biologic drugs into neurons to treat other disorders, Dong believes. Currently, most biologic drugs act only on cell-surface targets and cannot get into the cell's interior.

"We provide a protein-based drug delivery platform that achieves highly specific targeting of neurons and efficient penetration of cell membranes," Dong says. "Combined with nanobodies, which can be developed fairly readily against any protein of interest, this platform can be used to develop therapeutics that modulate proteins and biological processes inside neurons. Its modular nature even allows us to target cell types other than neurons by switching the cell-targeting domain. This could present a general approach for precision drug delivery into cells."

Credit: 
Boston Children's Hospital

Initial severity of COVID-19 not associated with later respiratory complications

image: Initial severity illness not associated with COVID-19 complications post-recovery.

Image: 
ATS

Jan. 8, 2021 - A new study published online in the Annals of the American Thoracic Society examines the recovery of lung function and overall wellness in individuals who had varying degrees of COVID-19 severity. Little is known about lung health following infection with SARS-CoV-2, the virus that causes COVID-19, and whether later respiratory problems, fatigue and ill health are associated with the disease's initial severity.

In "Persistent Poor Health Post-COVID-19 Is Not Associated With Respiratory Complications or Initial Disease Severity," Liam Townsend, MD, and co-authors looked at a number of measures of recovery for 153 patients who were followed in an outpatient clinic a median of 75 days after their COVID-19 diagnoses.

"We found that fatigue, ill-health and breathlessness were all common following COVID-19," said Dr. Townsend of the Department of Infectious Diseases, St. James's Hospital and Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College, Dublin, Ireland. "However, these symptoms appeared to be unrelated to the severity of initial infection or any single measurement at the time of an outpatient appointment."

Dr. Townsend and colleagues graded the patients' initial infection severity as: (1) not requiring admission; (2) requiring hospital admission, or (3) requiring ICU care. Nearly half (74) of these patients required hospital admission during acute infection.

The researchers examined the association between the patients' initial illness and abnormal chest x-ray, six-minute walk test distance--in which patients walked at their normal pace for six minutes--and perception of maximal exertion during their follow-up appointments. Patients were also asked about whether they felt fatigued and whether they thought they had returned to full health. Their responses were graded using validated scales.

The study team also looked at participants' chest x-rays in order to detect persistent infection or significant scarring (fibrosis) and performed CT imaging for patients with abnormal chest x-rays. Bloodwork was done to measure such indicators of disease as C-reactive protein, which increases when there is inflammation in the body. Statistical analyses were performed.

"We were surprised by our findings. We expected a greater number of abnormal chest x-rays. We also expected the measures of ongoing ill-health and abnormal findings to be related to severity of initial infection, which was not the case," Dr. Townsend said.

The authors' findings suggest that COVID-19 does not cause significant fibrosis, with lung scarring seen on CT scans of only 4 percent of study participants, following x-ray detection of earlier abnormalities in a larger group.

Sixty-two percent of patients felt they had not returned to full health, while 47 percent were classified as having fatigue. Patients who felt they had to exert themselves during moderate exercise also reported they felt fatigued and in poor health. Patients' length of inpatient hospital stays and frailty were associated with covering less distance in the walk test.

"These findings have implications for clinical care, in that they demonstrate the importance of following up all patients who were diagnosed with COVID-19, irrespective of severity of initial infection. It is not possible to predict who will have ongoing symptoms," Dr. Townsend stated.

Credit: 
American Thoracic Society

When salespeople advocate for sellers and customers

Researchers from Oklahoma State University, University of Missouri, Iowa State University, and University of Georgia published a new paper in the Journal of Marketing that investigates the question of how salespeople should balance advocacy for the seller with advocacy for the customer.

The study, forthcoming in the Journal of Marketing, is titled "Salesperson Dual Agency in Price Negotiations" and is authored by Justin Lawrence, Lisa Scheer, Andrew Crecelius, and Son Lam.

How should salespeople represent both the seller and the customer when their interests diverge, as in pricing negotiations? The research team extends a dual agency framework to the sales domain and examines the salesperson's role throughout the three stages of the discount process: (a) the customer's discount request, (b) the seller's approval, and (c) the seller's post-approval profit. This framework is tested across three multimethod studies and provides the first empirical investigation that deconstructs the sequential B2B customer-specific discount process.

The study concludes that the most favorable outcomes result when the salesperson engages in high levels of both customer advocacy and seller advocacy. As Lawrence explains, "Traditional agency theory research focuses on the salesperson as an agent of the seller. In contrast, we emphasize that the customer also considers the salesperson as its agent. As a result, the salesperson is unlikely to succeed as a seller advocate without also engaging in customer advocacy. For salespeople, our research offers guidance on a classic dilemma: the tension between the customer's desire for a lower price and the seller's insistence on demonstrating the value of its offering rather than compromising on price."

"Our findings are liberating for salespeople; they need not choose a side in discount negotiations. Instead, they can compartmentalize their duties. When dealing with the customer, they act as a fierce advocate for the seller; when dealing with seller personnel, they are a strong customer advocate" adds Scheer. This compartmentalization, somewhat paradoxically, enables the synergistic relationship between the two forms of advocacy and drives superior outcomes for both firms.

Although a salesperson's forceful advocacy on a customer's behalf may appear to threaten the seller's bottom line, sellers should consider that salesperson customer advocacy may be vital to a profitable relationship with the customer. Sellers are advised to encourage salespeople to serve as agents of their customers while also effectively acting as agents of the seller. Sales training programs, for example, can emphasize the importance of taking concrete actions to develop deep understanding of the customer's needs, effectively representing the customer's interests, and advocating forcefully for discounts and other seller concessions and assistance when warranted to bolster the customer's business and deepen the relationship.

One practical approach for sellers to leverage salesperson dual agency to their advantage is to encourage the development of multiple interfirm linkages with the customer, including cross-boundary interpersonal ties. Similarly, allowing a customer to learn more about the salesperson's customer advocacy amplifies the effectiveness of seller advocacy toward that customer. Following the seller's discount decision--even if the discount was denied--sales managers or pricing personnel can find ways to notify customers how the salesperson went to bat for them.

Customers should not hinder seller efforts to learn more about the salesperson's seller advocacy. For example, the seller might send the customer a survey asking about the salesperson's behaviors. Customers should view this as an opportunity to improve the seller's certainty about the salesperson's faithful representation. These findings differ from the implications of extant sales theories and prior sales research, which suggest that the salesperson serving two masters whose objectives are opposed (as with discounts) can lead to role stress and reduced performance.

Salespeople, sales managers, and organizational buyers can find value in this research. Whereas sellers warn salespeople not to 'be sold by the customer,' the findings suggest that sellers should encourage salespeople to advance the customer's agenda in discount negotiations. Engaging in seller advocacy, without customer advocacy, is likely to be ineffective or even lead to reduced seller profit. Customers and sellers can benefit from understanding that salesperson's advocacy for the other party is mutually beneficial and an important part of the salesperson's role.

Credit: 
American Marketing Association

High-speed atomic force microscopy visualizes cell protein factories

image: Model of translating ribosomes and elongation factors. EF1A•GTP•aatRNA and EF2 assemble to the ribosomal stalk on the translating ribosome. The translation factor pool contributes to efficient protein synthesis in a crowded intracellular environment.

Image: 
Proceedings of the National Academy of Sciences

Ribosomes are the complexes of ribonucleoproteins at the heart of protein synthesis in cells. However in the absence of conclusive evidence, how these complexes operate has been open to debate. Now Hirotatsu Imai and Noriyuki Kodera at Kanazawa University, alongside Toshio Uchiumi at Niigata University in Japan, show visualizations of the structural dynamics and factor pooling that take place at ribosome stalk proteins as they build new proteins.

Ribosomes were first discovered in the 1950s and their broad function has been widely understood for some time - they read messenger RNA sequences and from that generate sequences of correctly ordered amino acids into new proteins. The ribosome stalk protein in particular plays an integral role in the protein synthesis process by recruiting protein factors responsible for translation and elongation of the amino acid sequence. However it has been hard to satisfactorily establish the structure of the bound ribosome stalk protein because of its flexibility. Here the high resolution and fast image capture of high-speed atomic force microscopy proved invaluable.

Atomic force microscopy uses a nanoscale tip to feel samples, much like a vinyl record player needle scanning over a record, except that the details identified by an atomic force microscope can have atomic-scale resolution. The versatility of the technique for different surfaces was already a huge advantage for biological studies, but with the advent of high-speed atomic force microscopy the technique was able to capture dynamic processes for the first time as well. Imai, Uchiumi and Kodera used the technique to reveal that the stalk protein actually flips between two conformations - one that agrees with previous structural models and one entirely unexpected new conformation.

As for how the ribosome operates, a two step mechanism had been previously proposed to describe how genetic information is translated through proteins known as "translational GTPase factors". The first step is the recruitment of the factors to the factor-tethering site on the protein stalk, thereby increasing the concentration of factors there - so-called factor pooling. The second step is the binding and stabilizing of a translational GTPase on the ribosomal factor-binding center to catalyse GTPase hydrolysis. From their high speed atomic force microscopy study the researchers were able to obtain the first visual evidence for the translational GTPase factor pooling mechanism by the ribosomal stalk.

Although the study was unable to give conclusive evidence of the action of the factors once bound, the researchers did note that the factors appeared to be retained in the vicinity once GTPase hydrolysis was complete, suggesting a potential role of the stalk protein in further stages of protein synthesis. The researchers conclude, "future work with HS-AFM will provide further important information to understand the dynamic behaviors of these complex translational machineries."

Credit: 
Kanazawa University

Harbor porpoises on the decline in the German North Sea

image: Populations of harbor porpoises were surveyed from a plane

Image: 
D. Nachtsheim

The North Sea is a heavily trafficked area, with major shipping routes crossing its waters, and fisheries, offshore oil rigs, and wind farms populating its waves. All this activity inevitably has an effect on marine wildlife, and scientists are particularly interested in how the harbor porpoise population has fared in the face of such disturbances.

The harbor porpoise is known as a "sentinel species" - animals which indicate the health of an ecosystem and point to potential risks (think of the canary in the coal mine). According to a recent study published in Frontiers in Marine Science, their population is declining in the German North Sea.

"The trend seen here is concerning," says Dr Anita Gilles of the University of Veterinary Medicine Hannover, Germany, one of the study's authors. Particularly troubling is the fact that harbor porpoises have experienced a strong decline in protected areas, such as the Special Area of Conservation (SAC) Sylt Outer Reef, which was specifically designated to keep marine life safe. In that particular region, the harbor porpoise population declined by an average of 3.79% per year. In the south, however, the population increased, indicating a possible shift in distribution. Overall, the harbor porpoise population declined by 1.79% per year in the German North Sea.

In order to get an accurate abundance estimate, Gilles and her colleagues used a system in which the surveyed area was divided by transects into smaller blocks, then observed by plane. "Knowing the abundance of a population is at the heart of ecology, but extremely challenging for mobile species in a rapidly changing marine environment like the North Sea," she says. Their system is a standard method to determine wildlife population sizes, and includes measures to ensure accuracy, such as doubling back to account for diving porpoises. Additionally, an innovative analysis framework, developed by co-author Sacha Viquerat and based on the Bayesian paradigm, was implemented for trend analysis.

The study is also noteworthy for its two decades-long time span. "After almost 20 years of systematic data collection... we now have a wealth of data at hand," says Gilles. This data, while troubling, can help drive legislation to aid conservation efforts. "Abundance, distribution, and trends are key for EU and other legislative instruments, and for marine conservation management in general."

Moreover, co-author Dominik Nachtsteim is hopeful that their survey design and data analysis methods can be used in other regions where a dedicated monitoring concept needs to be implemented. Their study limited itself to the German North Sea, meaning that population counts and observed trends in the broader North Sea are missing.

As for why there are fewer harbor porpoises today than there were 20 years ago, Gilles and her colleagues hypothesize it might be due to an increase in human activities, a change in prey availability, a distribution shift. "Most probable, it is a mixture of different causes and cumulative effects," says Gilles. But because their study was focused on data collection and not understanding causes, "We urgently need more research into the drivers of change."

Credit: 
Frontiers

Free all non-violent criminals jailed on minor drug offences, say experts

Non-violent offenders serving time for drug use or possession should be freed immediately and their convictions erased, according to research published in the peer-reviewed The American Journal of Bioethics.

More than 60 international experts including bioethicists, psychologists and drug experts have joined forces to call for an end to the war on drugs which they argue feeds racism.

All drugs currently deemed illicit - even crack cocaine and heroin - should be decriminalized as a matter of urgency, according to this new alliance. Legalisation and regulation should then follow with restrictions on age, advertising and licensing, they say.

They have analysed evidence from over 150 studies and reports, concluding that prohibition unfairly affects Black people, damages communities, and violates the right to life as illustrated by the killing of medical worker Breonna Taylor in March 2020.

"The 'war on drugs' has explicitly racist roots and continues to disproportionately target certain communities of color," say lead study authors Brian D. Earp from the University of Oxford and Jonathan Lewis from Dublin City University.

"Drug prohibition and criminalization have been costly and ineffective since their inception. It's time for these failed policies to end.

"The first step is to decriminalize the personal use and possession of small amounts of all drugs currently deemed to be illicit, and to legalize and regulate cannabis. Policymakers should pursue these changes without further delay."

Their research adds to growing calls for drug policy reform at a time of renewed focus on injustices faced by Black people, and cannabis legalisation for recreational use by a growing list of US states.

The study is based on evidence from existing research into how drug prohibition affects users, communities and human rights, and the impact of decriminalisation by governments.

The authors found that prohibition motivates individuals to commit offences such as burglaries to fund their habit. This lowers life expectancy because people end up in prison, and triggers a 'multitude' of health-related costs from unsafe drug use.

Communities are damaged by illicit markets which undermine drug purity, with Black and Hispanic men more likely to end up in the criminal justice system. The war on drugs makes people more vulnerable to violations of their rights including what they choose to put in their bodies.

In contrast, the study highlights the liberal approach of countries such as Portugal where drug-related deaths have fallen and where users are encouraged to seek treatment.

An estimated £43.5bn ($58bn) could be generated in federal, state and local tax revenues through the legalization of drugs, according to the findings. This compares with an annual federal, state and local spend of more than £35bn ($47bn) on prohibition.

The authors stress that non-violent prisoners found with a small amount of illegal substances should be released.

Credit: 
Taylor & Francis Group

Cutting COVID-19 infectious period could prevent millions of cases

image: Results from PHICOR's computational simulation model show reductions in the contagious period of COVID-19 could avert thousands of hospitalizations and millions of cases and save billions of dollars.

Image: 
Sarah Rebbert/PHICOR, 2020 (CC-BY)

A new computational analysis suggests that a vaccine or medication that could shorten the infectious period of COVID-19 may potentially prevent millions of cases and save billions of dollars. The study was led by Bruce Lee along with colleagues in the Public Health Informatics, Computational, and Operations Research (PHICOR) team headquartered at the CUNY Graduate School of Public Health and Health Policy and the Lundquist Research Institute at Harbor-UCLA Medical Center, and publishes in the open-access journal PLOS Computational Biology.

While much of the public conversation surrounding COVID-19 vaccines and medications has focused on preventing or curing the infection, the vaccines and medications that may emerge could have subtler effects. Those that can't necessarily prevent or cure may still reduce how long someone is contagious.

To clarify the potential value of shortening the infectious period, Lee and colleagues created a computational model that simulates the spread of SARS-CoV-2, the virus that causes COVID-19. They used the model to explore how a vaccine or medication that can reduce the contagious period might alleviate the clinical and economic impact of the disease.

The simulations suggest that reducing the contagious period by half a day could avert up to 1.4 million cases and over 99,000 hospitalizations, saving $209.5 billion in direct medical and indirect costs--even if only a quarter of people with symptoms were treated--and incorporating conservative estimates of how contagious the virus may be. Under the same circumstances, cutting the contagious period by 3.5 days could avert up to 7.4 million cases. Expanding such treatment to 75 percent of everyone infected could avert 29.7 million cases and save $856 billion.

These findings could help guide research and investments into development of vaccines or medications that reduce the infectious period of SARS-CoV-2. They could also help government agencies plan rollout of such products and provide cost insights to guide reimbursement policies for third-party payers.

"There may be a tendency to overlook vaccines and other treatments that don't prevent a COVID-19 infection or cure disease," says Lee. "But this study showed that even relatively small changes in how long people are contagious can significantly affect the transmission and spread of the virus and thus save billions of dollars and avert millions of new cases."

"This study shows that vaccine and medication development efforts for COVID-19 should focus on the impact to actually help curb the spread of the COVID-19 pandemic, not just benefits of a single patient," says James McKinnell, a co-author of the study. "Widespread treatment, in combination with other prevention efforts, could prove to be the tipping point."

Credit: 
PLOS

Stem cell therapy corrects skull, brain function in mouse model of childhood disorder

image: A stem cell-based treatment given to young mice with craniosynostosis regenerated the flexible joints between skull bones and restored skull shape and size (right), compared to untreated animals (left), as shown in this 3D rendering.

Image: 
Amanda Frataccia, USC

Using stem cells to regenerate parts of the skull, scientists corrected skull shape and reversed learning and memory deficits in young mice with craniosynostosis, a condition estimated to affect 1 in every 2,500 infants born in the United States, according to the Centers for Disease Control and Prevention. The only current therapy is complex surgery within the first year of life, but skull defects often return afterward. The study, supported by the National Institute of Dental and Craniofacial Research (NIDCR), could pave the way for more effective and less invasive therapies for children with craniosynostosis. The findings were published Jan. 7, 2021 in Cell. NIDCR is part of the National Institutes of Health.

"This is a pivotal study demonstrating both structural regeneration and functional restoration in an animal model of craniosynostosis, said Lillian Shum, Ph.D., director of NIDCR's Division of Extramural Research. "It holds great potential for translation to treatment of the human condition."

Healthy infants are born with sutures--flexible tissue that fills the space between the skull bones--that allow the skull to expand as the brain grows rapidly in the first few years of life. In craniosynostosis, one or more sutures turn into bone too early, closing the gap between skull plates and leading to abnormal growth. The resulting increase in pressure inside the skull may cause physical changes in the brain that lead to thinking and learning problems.

"The connection between changes in the skull and the development of cognitive deficits had not been fully explored," said Yang Chai, D.D.S., Ph.D., director of the Center for Craniofacial Molecular Biology and associate dean of research at the Herman Ostrow School of Dentistry at the University of Southern California, Los Angeles, who led the study. "We wanted to know if restoring sutures could improve neurocognitive function in mice with mutations in a gene that causes craniosynostosis in both mice and humans."

That gene, called TWIST1, is thought to be important for suture formation during development. In humans, mutations in this gene can lead to Saethre-Chotzen syndrome, a genetic condition characterized by craniosynostosis and other skeletal abnormalities.

To see if flexible sutures could be restored in mice with craniosynostosis due to Twist1 mutations, the scientists focused on a group of stem cells normally found in healthy sutures. Previous studies by the group indicated that these stem cells--called Gli1+ cells--are key to keeping skull sutures of young mice intact. The team had also found that Gli1+ cells are depleted from the sutures of mice that develop craniosynostosis due to Twist1 mutations. Chai and his colleagues reasoned that replenishing the cells might help regenerate the flexible sutures in affected animals.

To test this idea, the researchers added Gli1+ cells from healthy mice to a biodegradable gel. They deposited the mixture into grooves meant to re-create the space where skull sutures had been in mice with craniosynostosis.

Skull imaging and tissue analysis revealed that after six months, new fibrous sutures had formed in treated areas and that the new tissue remained intact even after a year. In contrast, the same grooves closed in mice that received a gel that lacked Gli1+ cells.

Closer analysis showed that Gli1+ cells in the regrown sutures had different origins: some were descended from the cells that had been implanted, while others were the animals' own, having migrated from nearby areas. The findings suggest that Gli1+ cell implantation leads to suture regeneration in part by recruiting native Gli1+ stem cells to help in the process.

Further experiments showed that untreated mice with craniosynostosis had increased pressure inside their skulls and poor performance on tests of social and spatial memory and motor learning. After treatment, these measures all returned to levels typical of healthy mice. The skull shapes of treated mice were also partially corrected.

The treatment also reversed the loss of brain volume and nerve cells in areas involved in learning and memory. According to the scientists, this finding sheds light on the mechanisms underlying impaired brain function and its improvement after suture regeneration.

"We have discovered that Gli1+ stem-cell-based suture regeneration restores not only skull shape but also neurocognitive functions in a mouse model of craniosynostosis," said Chai.

The scientists note that more work remains before such an intervention can be tested in humans, including studies to determine the optimal timing of surgery and the ideal source and amount of stem cells.

"This study provides a foundation for efforts to develop a less-invasive, stem cell-based therapeutic strategy that can benefit patients who suffer from this devastating disorder," Chai said.

Credit: 
NIH/National Institute of Dental and Craniofacial Research

Archaeology: sharing leftover meat may have contributed to early dog domestication

Humans feeding leftover lean meat to wolves during harsh winters may have had a role in the early domestication of dogs, towards the end of the last ice age (14,000 to 29,000 years ago), according to a study published in Scientific Reports.

Maria Lahtinen and colleagues used simple energy content calculations to estimate how much energy would have been left over by humans from the meat of species they may have hunted 14,000 to 29,000 years that were also typical wolf prey species, such as horses, moose and deer. The authors hypothesized that if wolves and humans had hunted the same animals during harsh winters, humans would have killed wolves to reduce competition rather than domesticate them. With the exception of Mustelids such as weasels, the authors found that all prey species would have supplied more protein than humans could consume, resulting in excess lean meat that could be fed to wolves, thus reducing the competition for prey.

Although humans may have relied on an animal-based diet during winters when plant-based foods were limited, they were probably not adapted to an entirely protein-based diet and may have favoured meat rich in fat and grease over lean, protein-rich meat. As wolves can survive on a solely protein-based diet for months, humans may have fed excess lean meat to pet wolves, which may have enabled companionship even during harsh winter months. Feeding excess meat to wolves may have facilitated co-living with captured wolves and the use of pet wolves as hunting aids and guards may have further facilitated the domestication process, eventually to full dog domestication.

Credit: 
Scientific Reports

Policymakers draw heavily from highly cited COVID-19 science

Policymakers around the world tend to reference new and highly cited COVID-19 research papers in their policy documents regarding the pandemic, Yian Yin and colleagues conclude after analyzing publications of both types from the first half of 2020. "Overall, this result shows that the coronavirus research used by policymakers aligns with what scientists heavily engage themselves," they write in a Policy Forum. Although government agencies produced more COVID-19 documents compared to think tanks and intergovernmental organizations such as the World Health Organization, Yin et al. found that governmental agencies are the least likely to cite science. Organizations like WHO are the most likely institutions to cite science, they write, suggesting that these organizations can act as "central conduits" linking policy and science in the global COVID-19 response. The researchers examined scientific citations in policy documents drawn from a database of 37,725 papers covering most major world economies and populations centers, with the exception of mainland China. The policy documents have an unusually high rate of using the newest science--10 times larger than seen for other policy documents. And policymakers draw heavily from scientific papers that are highly cited in the scientific literature. Papers referenced in the policy documents have collected on average 40 times higher citations than papers not referenced in the documents, the researchers found. Yin et al. also note that policy papers disproportionately reference peer-reviewed research published in top medical and specialty journals, despite the recent abundance and attention given to research released on preprint servers.

Credit: 
American Association for the Advancement of Science (AAAS)

Social transmission of pain, fear has different targets in mouse brain

Social contact can transfer the feeling of pain or fear in several animal species, including humans, but the exact neural mechanisms for this transmission are still being studied. Now, Monique Smith and colleagues demonstrate that the social transmission of pain and pain relief in mice is mediated by neural projections from the brain's anterior cingulate cortex (ACC) to the nucleus accumbens. The transfer of fear, however, is mediated by the ACC's projections into a different area of the brain called the basolateral amygdala. The findings help untangle the distinct neural circuits involved in empathy, which in its simplest form is the ability to "feel" the affective states of others, say the researchers. A better understanding of how empathy is created in the brain "...may teach us about what goes wrong when empathy becomes maladaptive or is hampered as is the case in several psychiatric diseases," Alexandra Klein and Nadine Gogolla note in a related Perspective. In several experiments with mice, Smith et al. show how pain and fear can be socially transferred between affected and "bystander" mice, using a mix of visual, olfactory, and auditory cues. Using optogenetic methods, among others, they traced neuronal activity in the bystander mice to pinpoint exactly how the ACC induces this effect in the brain. The study also demonstrates for the first time that pain relief via an analgesic drug can be transferred socially, possibly offering an interesting model for socially-induced pain relief among humans, the researchers note.

Credit: 
American Association for the Advancement of Science (AAAS)

Tracking the formation of the early heart, cell by cell

Richard Tyser and colleagues have mapped the origins of the embryonic mouse heart at single-cell resolution, helping to define the cell types that make up the heart in the earliest days of development. Their techniques allowed them to identify for a first time a pool of progenitor cells that contributes to the formation of heart muscle cells as well as the early epicardium, the outermost layer of the heart. This layer provides cells and other proteins that guide the development and repair of heart tissue, so a better understanding of its origins could better inform regenerative heart therapies as well as improve our understanding of congenital heart defects. Tyser et al. performed a micro-dissection of a portion of the embryonic mouse heart to observe a very early stage streak of cells called the cardiac crescent transform into the linear heart tube. Combining single-cell RNA sequencing to identify cell types with high-resolution imaging and time-lapse microscopy, the researchers were able to follow the development of distinct populations of progenitor heart cells over about 12 hours of development.

Credit: 
American Association for the Advancement of Science (AAAS)